Literature DB >> 27453484

CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated Cytotoxicity.

Carlos J Blondel1, Joseph S Park2, Troy P Hubbard1, Alline R Pacheco1, Carole J Kuehl1, Michael J Walsh1, Brigid M Davis1, Benjamin E Gewurz1, John G Doench3, Matthew K Waldor4.   

Abstract

Type III secretion systems (T3SSs) inject bacterial effector proteins into host cells and underlie the virulence of many gram-negative pathogens. Studies have illuminated bacterial factors required for T3SS function, but the required host processes remain largely undefined. We coupled CRISPR/Cas9 genome editing technology with the cytotoxicity of two Vibrio parahaemolyticus T3SSs (T3SS1 and T3SS2) to identify human genome disruptions conferring resistance to T3SS-dependent cytotoxicity. We identity non-overlapping genes required for T3SS1- and T3SS2-mediated cytotoxicity. Genetic ablation of cell surface sulfation reduces bacterial adhesion and thereby alters the kinetics of T3SS1-mediated cytotoxicity. Cell surface fucosylation is required for T3SS2-dependent killing, and genetic inhibition of fucosylation prevents membrane insertion of the T3SS2 translocon complex. These findings reveal the importance of ubiquitous surface modifications for T3SS function, potentially explaining the broad tropism of V. parahaemolyticus, and highlight the utility of genome-wide CRISPR/Cas9 screens to discover processes underlying host-pathogen interactions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27453484      PMCID: PMC4982808          DOI: 10.1016/j.chom.2016.06.010

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  48 in total

1.  CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells.

Authors:  A Skoudy; J Mounier; A Aruffo; H Ohayon; P Gounon; P Sansonetti; G Tran Van Nhieu
Journal:  Cell Microbiol       Date:  2000-02       Impact factor: 3.715

2.  Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate.

Authors:  F Safaiyan; S O Kolset; K Prydz; E Gottfridsson; U Lindahl; M Salmivirta
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter.

Authors:  K Lühn; M K Wild; M Eckhardt; R Gerardy-Schahn; D Vestweber
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

4.  Precise region and the character of the pathogenicity island in clinical Vibrio parahaemolyticus strains.

Authors:  Tomohiko Sugiyama; Tetsuya Iida; Kaori Izutsu; Kwon-Sam Park; Takeshi Honda
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

5.  Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells.

Authors:  Richard D Hayward; Robert J Cain; Emma J McGhie; Neil Phillips; Matthew J Garner; Vassilis Koronakis
Journal:  Mol Microbiol       Date:  2005-05       Impact factor: 3.501

6.  Functional characterization of two type III secretion systems of Vibrio parahaemolyticus.

Authors:  Kwon-Sam Park; Takahiro Ono; Mitsuhiro Rokuda; Myoung-Ho Jang; Kazuhisa Okada; Tetsuya Iida; Takeshi Honda
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Molecular cloning and identification of 3'-phosphoadenosine 5'-phosphosulfate transporter.

Authors:  Shin Kamiyama; Takeshi Suda; Ryu Ueda; Masayuki Suzuki; Reiko Okubo; Norihiro Kikuchi; Yasunori Chiba; Satoshi Goto; Hidenao Toyoda; Kaoru Saigo; Masahiko Watanabe; Hisashi Narimatsu; Yoshifumi Jigami; Shoko Nishihara
Journal:  J Biol Chem       Date:  2003-04-25       Impact factor: 5.157

8.  Identification and characterization of VopT, a novel ADP-ribosyltransferase effector protein secreted via the Vibrio parahaemolyticus type III secretion system 2.

Authors:  Toshio Kodama; Mitsuhiro Rokuda; Kwon-Sam Park; Vlademir V Cantarelli; Shigeaki Matsuda; Tetsuya Iida; Takeshi Honda
Journal:  Cell Microbiol       Date:  2007-07-23       Impact factor: 3.715

Review 9.  Fucose: biosynthesis and biological function in mammals.

Authors:  Daniel J Becker; John B Lowe
Journal:  Glycobiology       Date:  2003-03-19       Impact factor: 4.313

10.  Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction.

Authors:  Frank Lafont; Guy Tran Van Nhieu; Kentaro Hanada; Philippe Sansonetti; F Gisou van der Goot
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

View more
  30 in total

1.  Type I interferon remodels lysosome function and modifies intestinal epithelial defense.

Authors:  Hailong Zhang; Abdelrahim Zoued; Xu Liu; Brandon Sit; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-10       Impact factor: 11.205

Review 2.  Cross-species RNA-seq for deciphering host-microbe interactions.

Authors:  Alexander J Westermann; Jörg Vogel
Journal:  Nat Rev Genet       Date:  2021-02-17       Impact factor: 53.242

Review 3.  Assembly, structure, function and regulation of type III secretion systems.

Authors:  Wanyin Deng; Natalie C Marshall; Jennifer L Rowland; James M McCoy; Liam J Worrall; Andrew S Santos; Natalie C J Strynadka; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2017-04-10       Impact factor: 60.633

Review 4.  Design and analysis of CRISPR-Cas experiments.

Authors:  Ruth E Hanna; John G Doench
Journal:  Nat Biotechnol       Date:  2020-04-13       Impact factor: 54.908

Review 5.  CRISPR/Cas9 library screening for drug target discovery.

Authors:  Morito Kurata; Kouhei Yamamoto; Branden S Moriarity; Masanobu Kitagawa; David A Largaespada
Journal:  J Hum Genet       Date:  2017-11-20       Impact factor: 3.172

Review 6.  Am I ready for CRISPR? A user's guide to genetic screens.

Authors:  John G Doench
Journal:  Nat Rev Genet       Date:  2017-12-04       Impact factor: 53.242

7.  Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.

Authors:  Julia Joung; Silvana Konermann; Jonathan S Gootenberg; Omar O Abudayyeh; Randall J Platt; Mark D Brigham; Neville E Sanjana; Feng Zhang
Journal:  Nat Protoc       Date:  2017-03-23       Impact factor: 13.491

Review 8.  Epithelial glycosylation in gut homeostasis and inflammation.

Authors:  Yoshiyuki Goto; Satoshi Uematsu; Hiroshi Kiyono
Journal:  Nat Immunol       Date:  2016-10-19       Impact factor: 25.606

Review 9.  Beyond Hemoglobin: Screening for Malaria Host Factors.

Authors:  Elizabeth S Egan
Journal:  Trends Genet       Date:  2017-12-14       Impact factor: 11.639

10.  Cell-type-specific hypertranslocation of effectors by the Pseudomonas aeruginosa type III secretion system.

Authors:  Erin I Armentrout; Emma C Kundracik; Arne Rietsch
Journal:  Mol Microbiol       Date:  2020-11-05       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.